Stockreport

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2025 Results and Provides Business Update

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF - 2025 net product sales of $521 million- 2026 expected global net product sales of $630 million to $650 million- Volixibat VISTAS study in PSC topline data expected Q2 [Read more]